However, the proportion of patients referred to a health care facility increased from 23% to 33.5% over the study period.The authors say many of these errors were preventable and could be reduced through better patient education.The findings were recently published in the Journal of Medical Toxicology.More informationAmerica's Poison Centers has more on GLP-1s and overdose.SOURCE: HealthDay TV, June 25, 2026 .What This Means For YouAs GLP-1 weight-loss drugs become more popular, medication mistakes are becoming more common, underscoring the need for clearer instructions and patient education..Sign up for our weekly HealthDay newsletter
The nationwide poll was conducted January 9-13, 2025 using the AmeriSpeak Panel, the probability-based panel of NORC at the University of Chicago
On the tirzepatide side, tirzepatide with levocarnitine and tirzepatide with niacinamide offer similar enhancement options
Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs
The GLP-1RAs used in these studies included shorter-acting liraglutide and once-weekly semaglutide, with maximum doses of 3 mg and 2.4 mg, respectively